Age of Red Cells for Transfusion and Outcomes in Critically Ill Adults
D James Cooper, Zoe K McQuilten, Alistair Nichol, Bridget Ady, Cecile Aubron, Michael Bailey, Rinaldo Bellomo, Dashiell Gantner, David O Irving, Kirsi-Maija Kaukonen, Colin McArthur, Lynne Murray, Ville Pettila, Craig French
New England Journal of Medicine | MASSACHUSETTS MEDICAL SOC | Published : 2017
Awarded by Australian National Health and Medical Research Council (NHMRC)
Awarded by Health Research Council of New Zealand
Awarded by Irish Health Research Board
Supported by grants from the Australian National Health and Medical Research Council (NHMRC) (APP102064 and APP1040971), the Health Research Council of New Zealand (12/575), and the Irish Health Research Board (HRA-DI-2014-589 and CTN-2014-012) and by funding from the Australian Red Cross Blood Service. Federal and state governments of Australia fund the Australian Red Cross Blood Service for the provision of blood, blood products, and services to the Australian community. The Medical Research Institute of New Zealand is supported by independent-research-organization funding from the Health Research Council of New Zealand. Drs. Cooper and Bellomo are NHMRC Practitioner Fellows (APPS436629/1041922 and APPS469001/1044787, respectively); Dr. McQuilten is an NHMRC Early Career Fellow (APP1111485).Dr. Cooper reports receiving consulting fees, paid to Monash University, from Eustralis Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.